J Korean Soc Pediatr Endocrinol.  2007 Jun;12(1):77-81.

Growth Hormone Therapy in Russell-Silver Syndrome

Affiliations
  • 1Department of Pediatrics, Keimyung University School of Medicine, Daegu, Korea. kimhs@dsmc.or.kr

Abstract

Russell-Silver syndrome is characterized by low birth weight, growth retardation, delayed bone age, asymmetry, abnormal sexual development, cranio-facial disproportion, short little finger and clinodactyly. Short stature is the major concern, so there have been interests treating Russell-Silver syndrome with human growth hormone. However, there are no large-scale controlled studies to confirm the effectiveness of growth hormone therapy until now because of the rarity of this disorder. In Korea, we cannot find reports dealing with growth hormone treatment in Russell-Silver syndrome. We present three children with Russell-Silver syndrome who showed accelerated growth with growth hormone treatment.

Keyword

Russell-Silver syndrome; Growth hormone

MeSH Terms

Child
Fingers
Growth Hormone*
Human Growth Hormone
Humans
Infant, Low Birth Weight
Infant, Newborn
Korea
Sexual Development
Silver-Russell Syndrome*
Growth Hormone
Human Growth Hormone
Full Text Links
  • JKSPE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr